Since the inception of the Pharmaceutical Benefits Scheme (PBS) in the late 1940s there has been a dramatic increase in the range of medicines that are available to the Australian community. The simultaneous rise in the prevalence of chronic disease means that many patients are taking multiple medicines on a long term basis, with a concommitent increased risk of drug related problems including adverse effects, and drug-drug interactions and drug-disease interactions.Oliver Frank, Chris Alderma
Background: The increasing burden of chronic (medical) conditions (CCs) is a major issue for healthc...
Aim. To determine whether the national declines in prescription medicine use occurring after the 200...
Introduction Drug related problems (DRPs) are a common cause of morbidity and mortality. The resolu...
THE FUNDING CRISIS in the Pharmaceutical Benefits Scheme poses the greatest threat to its existence ...
The definitive version may be found at www.wiley.comObjectiveTo determine whether a 24% increase in ...
Harm caused by ill-effects of prescribed drugs is largely unrecognised, but when looked for has been...
In November 1990 major patient co-payment changes were introduced into the Pharmaceutical Benefits S...
The definitive version may be found at www.wiley.comPurposePatient co-payments for medicines subsidi...
Most pharmaceuticals in Australia are provided under the Pharmaceuticals Benefits Scheme (PBS) admin...
Australia has had a government subsi dized universal system of pharmaceutical provision for 50 years...
Pharmacotherapy is an essential component of medical care for older patients, and around two-thirds ...
The Pharmaceutical Benefits Scheme (PBS) has served the Australian community well. Increased growth ...
Prescription medicine samples (or starter packs) are provided by pharmaceutical manufacturers to pre...
Finding ways of curbing government expenditure on the PBS while maintaining social equity and access...
BACKGROUND: Opioid prescribing/dispensing data can inform policy surrounding regulation by informing...
Background: The increasing burden of chronic (medical) conditions (CCs) is a major issue for healthc...
Aim. To determine whether the national declines in prescription medicine use occurring after the 200...
Introduction Drug related problems (DRPs) are a common cause of morbidity and mortality. The resolu...
THE FUNDING CRISIS in the Pharmaceutical Benefits Scheme poses the greatest threat to its existence ...
The definitive version may be found at www.wiley.comObjectiveTo determine whether a 24% increase in ...
Harm caused by ill-effects of prescribed drugs is largely unrecognised, but when looked for has been...
In November 1990 major patient co-payment changes were introduced into the Pharmaceutical Benefits S...
The definitive version may be found at www.wiley.comPurposePatient co-payments for medicines subsidi...
Most pharmaceuticals in Australia are provided under the Pharmaceuticals Benefits Scheme (PBS) admin...
Australia has had a government subsi dized universal system of pharmaceutical provision for 50 years...
Pharmacotherapy is an essential component of medical care for older patients, and around two-thirds ...
The Pharmaceutical Benefits Scheme (PBS) has served the Australian community well. Increased growth ...
Prescription medicine samples (or starter packs) are provided by pharmaceutical manufacturers to pre...
Finding ways of curbing government expenditure on the PBS while maintaining social equity and access...
BACKGROUND: Opioid prescribing/dispensing data can inform policy surrounding regulation by informing...
Background: The increasing burden of chronic (medical) conditions (CCs) is a major issue for healthc...
Aim. To determine whether the national declines in prescription medicine use occurring after the 200...
Introduction Drug related problems (DRPs) are a common cause of morbidity and mortality. The resolu...